Stay on top of United States latest developments on the ground with Al Jazeera’s fact-based news, exclusive video footage, photos and updated maps.

Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee at its meeting last week, but the same panel had ...